PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits by Ziebarth, Jesse D. et al.
PolymiRTS Database 2.0: linking polymorphisms





1,2,3 and Yan Cui
1,2,*
1Department of Microbiology, Immunology and Biochemistry,
2Center for Integrative and Translational
Genomics, University of Tennessee Health Science Center, Memphis, TN 38163, USA and
3College of
Computer Science and Engineering, University of Electronic Science and Technology of China, Chengdu
610054, China
Received September 14, 2011; Revised October 19, 2011; Accepted October 21, 2011
ABSTRACT
The polymorphism in microRNA target site
(PolymiRTS) database aims to identify single-
nucleotide polymorphisms (SNPs) that affect
miRNA targeting in human and mouse. These poly-
morphisms can disrupt the regulation of gene ex-
pression by miRNAs and are candidate genetic
variants responsible for transcriptional and pheno-
typic variation. The database is therefore organized
to provide links between SNPs in miRNA target
sites, cis-acting expression quantitative trait loci
(eQTLs), and the results of genome-wide associ-
ation studies (GWAS) of human diseases. Here, we
describe new features that have been integrated in
the PolymiRTS database, including: (i) polymiRTSs
in genes associated with human diseases and
traits in GWAS, (ii) polymorphisms in target sites
that have been supported by a variety of experimen-
tal methods and (iii) polymorphisms in miRNA seed
regions. A large number of newly identified
microRNAs and SNPs, recently published mouse
phenotypes, and human and mouse eQTLs have
also been integrated into the database. The
PolymiRTS database is available at http://compbio
.uthsc.edu/miRSNP/.
INTRODUCTION
A primary, and often elusive, goal of genetics studies is
identifying the speciﬁc genetic variants that cause individ-
ual variation in complex traits. One class of genetic
variants that have been shown to impact gene expression
and higher order traits is DNA polymorphisms that alter
microRNA targeting. Polymorphisms in microRNA
target sites (PolymiRTSs) have been associated with a
wide range of diseases (1,2), including cancers (3–5),
Parkinson disease (6), osteoporosis (7), diabetes (8) and
hypertension (9). MicroRNAs are short ( 22nt)
non-coding RNAs that function as post-transcriptional
regulators of genes, repressing mRNA translation and
causing mRNA decay (10). It has been estimated that
miRNAs may regulate  60% of all human genes. While
the mechanism through which the speciﬁc mRNA targets
of a miRNA are selected has yet to be completely under-
stood, one common feature of many miRNA–mRNA
pairs is sequence complementarity between the 50-end, or
seed region, of the mature form of the miRNA and a
target site in the 30-UTR of the mRNA. Because of this
complementarity in miRNA binding, genetic variants,
such as single-nucleotide polymorphisms (SNPs), in
these sites can disrupt miRNA binding sites or create
new binding sites, resulting in variation in both the
levels of gene expression and, potentially, higher order
traits across individuals.
We introduced the PolymiRTS database (11) (http://
compbio.uthsc.edu/miRSNP/) to collect SNPs in putative
miRNA target sites in human and mouse genomes and
identify their possible implications in transcriptional and
phenotypic variation. Speciﬁcally, the original version of
the database integrated SNPs in predicted miRNA target
sites in the 30-UTRs of mRNAs with quantitative trait loci
(QTLs) for both mRNA expression traits and higher-
order phenotypes. The database is therefore organized
to provide links between SNPs in mRNA target sites,
cis-acting expression QTLs (eQTLs) and physiological
QTLs. Since the introduction of the PolymiRTS
database, several advances have been made in identifying
both the targets of miRNAs and the polymorphisms that
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of genome-wide association studies (GWAS) in recent
years has made it increasingly possible to link polymorph-
isms, such as those contained in the PolymiRTS database,
with human diseases and traits. Additionally, new
sequencing approaches, such as cross-linked immunopre-
cipitation sequencing (CLIP-Seq), have enabled the deter-
mination of the mRNA sequences that interact with
miRNAs (12,13). In light of these advances, we have
updated the PolymiRTS database to improve its utility
as a tool for understanding how miRNA-related poly-
morphisms impact complex traits.
NEW FEATURES
We have both expanded the PolymiRTS database and
added several new features, with a focus on incorporating
information from experimental data sources, including
GWAS and CLIP-Seq (Figure 1 and Table 1). New
content in this update of the PolymiRTS database
includes:
(i) Polymorphic miRNA targets that have been linked
to human diseases and traits in GWAS. The
PolymiRTS database includes over 3000 genes that
Figure 1. Overview of PolymiRTS 2.0. The database integrates genomic, expression and complex trait data which can be accessed through a variety
of browse and search options. New features in the database have a red background. A sample entry in the database is also shown.
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GWAS and contain polymorphisms in predicted and
experimentally supported miRNA binding sites.
(ii) Polymorphisms in experimentally supported
miRNA target sites. Recently, new techniques,
such as CLIP-Seq (12,13) and allelic imbalance se-
quencing (14), have been introduced and enabled
more efﬁcient experimental identiﬁcation of
microRNA targets. SNPs in miRNA target sites dis-
covered using these techniques, as well as experi-
mentally supported miRNA target sites in several
databases (15–17), have been identiﬁed and are
available for searching and browsing in the
database.
(iii) Polymorphisms in miRNA seed regions. SNPs in
miRNA seed regions have potentially wide-spread
effects, as the change in seed sequence may disrupt
the binding of the miRNA to all of its original tar-
gets and redirect it to new target genes, and have
been linked with complex traits. For example, poly-
morphisms in the seed region of miR-96 have been
associated with hearing loss in humans (18) and
mice (19) and
(iv) A signiﬁcantly expanded number of expression QTL
datasets. Variation in gene expression caused by a
polymiRTS may result in detection of a cis-eQTL in
microarray or RNA-Seq data. We have added cis-
eQTLs from several studies in mouse and human,
including those in the GTEx eQTL browser, to the
polymiRTS database to identify the genetic variants
that may cause these cis-eQTLs.
DATABASE CONTENT
SNPs in predicted and experimentally validated miRNA
target sites
The main table in the original version of the PolymiRTS
database contained SNPs in predicted miRNA target sites
for human and mouse. We have updated this table follow-
ing the same general workﬂow outlined in our previous
paper (11), utilizing the latest versions of publically avail-
able databases (as of August 2011). We ﬁrst identiﬁed all
SNPs in dbSNP build 132 (20,21) that were in 30-UTRs of
mRNAs and used Galaxy (22–24) to obtain the sequences
surrounding these SNPs in the human and mouse genomes
(hg19 and mm9). Mature miRNA sequences were down-
loaded from miRBase 17 (25). The seed regions of the
miRNAs were compared to the 30-UTR sequences to de-
termine if the SNPs affected complementarity between the
seed and potential target sequences. We used the criteria
of TargetScan (26) in the prediction of miRNA sites,
which requires a perfect Watson–Crick match to the
seed nucleotides 2–7 of miRNA, and either a perfect
match to the 8th nucleotide of the miRNA or an anchor
adenosine immediately downstream of the 2–7 seed in the
target. We then classiﬁed predicted target sites containing
SNPs into one of four functional classes. The four func-
tional classes were deﬁned as follows: (i) O: the ancestral
allele could not be determined, (ii) D: the derived allele
disrupts a target site that was conserved in two or more
other vertebrate genomes based on the 46-way Multiz
alignment, (iii) N: the derived allele disrupts a
non-conserved target site and (iv) C: the derived allele
creates a new miRNA site. The ancestral allele for each
SNP was determined through comparison with the rat
(rn4) and chimpanzee (panTro2) genomes for mouse and
human, respectively.
SNPs in experimentally supported target sites
While computationally predicted miRNA target sites have
been successfully used for several applications, they still
result in a large number of false positives (27,28), making
experimentally determined and validated target sites of
great interest. We have therefore added experimentally
determined miRNA target sites from a variety of experi-
mental sources to the PolymiRTS database. First, we used
three databases, miRecords (16), TarBase (15) and
miRTarBase (17), that contain collections of miRNA
targets from both low- and high-throughput experiments.
The large majority of the entries in these databases
contain only the miRNA–mRNA pairs that interact, not
the speciﬁc location of the miRNA target site. For these
cases, we scanned the entire 30-UTR region of the mRNA
for predicted binding sites of the interacting miRNA that
included SNPs, as described earlier. These experimentally
supported entries in the PolymiRTS database, where the
speciﬁc locations of the miRNA target sites were not
provided by the experiment, are labeled with the classes
HT or LT depending on whether miRNA-mRNA target
pair was determined from high-throughput (e.g. micro-
array or pSILAC) or low-throughput (e.g. luciferase
reporter assay or western blot) methods, respectively.
Additionally, several experimental techniques, such as
the HITS-CLIP (13) and PAR-CLIP (12), have recently
been developed and used to identify the speciﬁc mRNA
sequences that bind with miRNAs in the RNA-inducing
silencing complex (RISC). To include data from these ex-
periments, we ﬁrst obtained the mRNA sequences bound
in RISCs from ago.rockefeller.edu, which is associated
with the HITS-CLIP experiment, and the Supplementary
Material from Ref. (12). We then determined if these se-
quences contained SNPs that would disrupt miRNA
Table 1. Summary of data available in PolymiRTS database
Type of data Number of records
Human Mouse
miRNAs 1733 1111
SNPs in predicted miRNA target sites 117167 112763
SNPs in experimentally supported
miRNA target sites
1117 426
SNPs in miRNA seeds 20 5




Genes associated with human traits in GWAS 3509 NA
Genes associated with BXD phenotype QTLs NA 2331
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method are labeled with the code HTL to indicate that
the target site was identiﬁed using a high-throughput
method that provides the speciﬁc location information
about the target site. Finally, alleleic imbalance sequenc-
ing has recently been proposed as an experimental method
to determine if SNPs in miRNA target sites impact expres-
sion of the target (14). The allelic imbalance for 67
predicted target sites of three miRNAs in mouse was
measured, and it was determined that at least 16% of
these target sites were functional. We included the 11
(67 0.16=10.7) target sites with the highest allelic im-
balance ratios, and labeled them with the code LTL,
indicating that the speciﬁc location of the miRNA target
in the mRNA was conﬁrmed through a low-throughput
experimental method.
SNPs in miRNA seed regions
With the increasing number of SNPs entries in dbSNP and
annotated miRNAs in miRBase, it has become practical
to identify SNPs in miRNAs. A SNP in a miRNA seed
region may impact the binding of several hundred targets.
We identiﬁed 5 and 20 SNPs in miRNA seed regions for
mouse and human, respectively. We extracted the entire
30-UTR of all genes in Enesembl Biomart (29) for the
mouse and human genomes and used the criteria discussed
earlier to identify all predicted target sites that would be
either disrupted or created by the SNPs in the miRNA
seed regions. Disrupted sites are predicted targets of the
miRNAs with the reference allele at the SNP location,
while the created sites are predicted targets of the
miRNA with the derived allele.
PolymiRTS in cis-acting eQTLs
Polymorphisms that disrupt miRNA binding may be the
causal variants that underlie cis-acting expression QTLs
(eQTLs). We have extensively increased the datasets used
to identify gene regulated by cis-eQTLs in mouse and
human. For mouse, eQTL mapping results for gene ex-
pression were accessed from publically available datasets
in the GeneNetwork (www.genenetwork.org) browser. We
included eQTLs in nine tissues (whole brain, cerebellum,
eye, hippocampus, kidney, liver, nucleus accumbens, pre-
frontal cortex and retina) in the BXD recombinant inbred
panel in PolymiRTS. Gene expression levels were treated
as quantitative traits and were mapped onto genomic re-
gions (eQTL) using standard marker regression. A gene is
said to have a signiﬁcant cis-acting eQTL if the QTL peak
location is within 5Mb from the gene’s physical location
and the genome-wide adjusted P-value was  0.05.
We have also added eQTLs identiﬁed in several human
tissues to the database. The GTEx eQTL browser (http://
www.ncbi.nlm.nih.gov/gtex/test/GTEX2/gtex.cgi) cur-
rently includes eQTL mapping results for seven data sets
across six tissues and cell lines (liver, cerebellum, frontal
cortex, temporal cortex, pons and lymphblastoid cells).
These eQTLs from GTEx were downloaded and ﬁltered
to select cis-eQTLs by identifying the marker with the
minimum P-value within 1Mb of the gene. Additionally,
cis-eQTLs in four studies (not in GTEx) of expression
genetics in the human skin (30), cortex (31), monocytes
(32) and lymphoblastoid cells (33) were also added to
polymiRTS. The methods and signiﬁcance criteria used
in identifying cis-eQTLs in each of these four studies
were maintained.
PolymiRTS in physiological QTLs and disease genes
The main goal of many genetic studies is to determine the
polymorphisms that cause variation in complex traits and
diseases. For mouse, we identiﬁed polymorphisms and
genes that may impact complex traits by mapping QTLs
(genome-wide adjusted P-value  0.1) for more than 2000
published BXD phenotypes (physiological and behavioral
traits) available in GeneNetwork. For each QTL, we
linked it with genes that are located in the QTL interval
and have at least one PolymiRTS. These genes, together
with genes with other types of potentially functional
sequence variations, are candidate causal genes underlying
the physiological and disease QTLs.
To associate genes containing polymorphisms in
miRNA target sites with human diseases and traits, we
utilized results from GWAS available in the NHGRI
GWAS Catalog (34) and dbGaP (35). We ﬁrst used
these databases to collect the genes that contain or are
located nearby the polymorphisms that have been linked
to complex traits in the GWAS. Then, we found the inter-
section of this list of GWAS-identiﬁed genes with the list
of genes containing SNPs in predicted and experimentally
supported miRNA target sites. The polymiRTSs in these
genes are potential causal genetic variants that underlie
the GWAS results.
DATABASE ACCESS
The PolymiRTS interface has been modiﬁed to allow for
quick access to polymorphisms that are of high interest
and to the new features that have been included in this
update. Speciﬁcally, we have added new tables to the data-
base which are accessible via the Browse link on the
PolymiRTS homepage. The database now includes the fol-
lowing browsable tables: (i) genes with SNPs in miRNA
target sites, (ii) SNPs in miRNA seeds, (iii) human diseases
and traits, which contains human diseases and traits that
have been linked to genes with SNPs in miRNA target sites
in GWAS and (iv) experimentally supported targets,
which contains only the SNPs in miRNA target sites
with experimental support. Users are also able to search
the database by SNP, miRNA, gene, complex trait and
gene ontology, as well as perform a chromosome location
search to select all entries in PolymiRTS between two
genomic locations, which may be used by researchers
looking for functional polymorphisms that underlie a
physiological QTL. Both the browsable tables and search
results can be ﬁltered to select only entries in the database
with speciﬁc functional classes, experimental support or
high levels of conservation across species. Tab-delimited
text ﬁles containing all of the tables used in the database
are also available for download.
The main method of viewing the records in PolymiRTS
is a webpage page separated into ﬁve sections, which lists
Nucleic Acids Research, 2012,Vol.40, Database issue D219all data in the database pertaining to a particular gene
(Figure 1). The ﬁve sections on this page are: (i) a gene
description section listing the RefSeqID, gene symbol,
gene description and genomic location, as well as, for
genes with a human/mouse ortholog, the ortholog gene
and a link to the record in PolymiRTS in the other
species, if available; (ii) a table of SNPs in miRNA
target sites in the 30-UTR regions of the gene, which
provides the genomic location and miRNAs that target
the site, as well as the functional class and evolutionary
conservation of the target site; (iii) tables of predicted
targets sites that are either created or disrupted by SNPs
in miRNA seeds; (iv) a table of tissues in which the gene is
regulated by cis-acting eQTLs and (v) a table listing asso-
ciations with complex traits. For human genes, the asso-
ciations with complex traits section provide the title of the
study establishing the link between the gene and the trait
as well as a link to the study’s PubMed entry.
DISCUSSION AND FUTURE DIRECTIONS
One of the limiting factors in understanding the impact of
miRNAs on complex traits has been in identifying the
mRNA sequences that are targeted by miRNAs, and, in
response, several computational methods have been de-
veloped to predict these target sites (36–38). These
methods have traditionally been based on complementar-
ity between miRNA seeds and mRNA sequences and con-
servation of mRNA sequences across species; however,
other criteria including thermodynamics, target site acces-
sibility and features of the sequence surrounding the
predicted binding site have been used. Because of the rela-
tively small number of experimentally validated miRNA
targets, it has been difﬁcult to thoroughly evaluate the
performance of these algorithms, and the existing com-
parisons of computational predictions with experimental
results have shown that the predictions have high false
positive rates, particularly for non-conserved sites
(27,28). As there has yet to be a clear winner among
target prediction algorithms, we have continued to use a
simple method of predicting target sites in the PolymiRTS
database that uses only seed-target complementarity and,
if the user chooses, conservation, allowing users the choice
of displaying all potential target sites or only those sites
with high conservation.
Due to the limitations of computational target predic-
tions, we have added results from a large number of the
existing experimentally supported miRNA–mRNA inter-
actions in PolymiRTS. While many of these results rely on
computationalalgorithmsto determine thepreciselocation
on the mRNA that is the miRNA target site, recent ex-
perimental techniques, such as CLIP-Seq and allelic im-
balance sequencing, can provide the speciﬁc miRNA
target sequence. These experiments have the ability to
improve the quality of databases such as PolymiRTS
because they not only have the potential to greatly increase
the number of experimentally validated miRNA targets,
but they also provide a training set that can be used to
improve computational prediction of target sites.
The expansion of the PolymiRTS database in this
update increases its usefulness to researchers investigating
the impact of polymorphisms on miRNA-mediated bio-
logical processes. The inclusion of experimentally sup-
ported target sites and SNPs associated with human
traits and diseases in GWAS will enable users to select
SNPs of high-interest to understanding the effect of
these genetic variations on gene expression and complex
traits. In the future, we expect PolymiRTS to continue to
grow with the increasing availability of data in resources
such as GTEx and dbGaP. One area that we can see
PolymiRTS improving greatly in the future is in having
improved methods for prediction and identiﬁcation of
miRNA target sites. We will perform quarterly searches
for updates to databases such as miRTarBase and
miRecords as well as for new data sets containing
targets determined from CLIP-Seq or similar experimental
methods in order to include new experimentally supported
miRNA–mRNA interactions in PolymiRTS as they
become available. Also, the improvements to computa-
tional prediction algorithms facilitated by these experi-
ments will be used to enable selection of only high
conﬁdence targets sites in the PolymiRTS database.
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